Skip to main content

The Post Exposure Prophylactic Measures Against Viral BTW Agents

  • Chapter
The Role of Biotechnology in Countering BTW Agents

Part of the book series: NATO Science Series ((ASDT,volume 34))

  • 159 Accesses

Abstract

Viruses do not have their own energy supplying and structural-components synthesizing systems. That is the main difference between viruses and such pathogens as bacteria and rickettsia. Therefore they have to use intracellular structures and enzymes for their replication, so the critical stage of their reproduction is the stage at which they penetrate the cell. Once they have entered the cell viruses do not leave it until multiplying and fully maturating after which they can infect hundreds or even thousands of new cells. Bacteria do not really need cellular structures for their replication because their main requirements are energy sources and elementary structural components, such as amino acids, nucleic acids, carbohydrates, fatty acids or their components. The main, if not the only, way to defeat a virus is to attack it before it enters the living cell, whereas bacteria may be attacked throughout their life cycle taking place in a macroorganism. The time interval before a virus enters the eucaryotic cell or attacks the critical organ is sometimes prolonged. This allows the use of drugs or preparations for diminishing the symptoms or even for preventing the disease itself. One striking example has recently been sent for publication by researchers of our Center. The manuscript describes the preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infection [21]. In this chapter I would like to present some results from this publication, together with other data about preparations for post exposure prophylaxis of viral infections.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lange, G.V., McCormick, G.B., Walker, D.H. Kiley, M.P., and Neidhardt F.S. (1985) Vaccination of rhesus monkey by gamma-inactivated Ebola virus and results of live virus challenge in immune and native animalsAbstr. Ann. Meet. Amer. Soc. Microbiol.Las Vegas, Nevada, 3–7 March, 1985; CDC, Atlanta; p. 295.

    Google Scholar 

  2. Lupton, H.W., Lambert, R.D., Bumgardner, D.L., Moe, J.B., and Eddy, G.A. (1980) Inactivated vaccine for Ebola virus efficacious in guinea pig modelLancet 2(8207)1294–1295.

    Article  Google Scholar 

  3. Mikhailov, V.V., Borisevich, I.V., Chernikova, N.K., Potryvaeva, N.V., and Krasnianskii, V.P. (1994) The evaluation in hamadyas baboons of the possibility for the specific prevention of Ebola feverVoprosy Virusologii(in Russian)39(2)82–84.

    Google Scholar 

  4. Ignatyev, G.M., Streltsova, M.A., Agafonov, A.P., and Kashentseva, E.A. (1995) Mechanisms of protective immune response in monkeys with Marburg virusVoprosy Virusologii(in Russian)40(3)109–113.

    Google Scholar 

  5. Chepurnov, A.A., Chernukhin, I.V., Ternovoi, V.A., Kudoiarova, N.M., Makhova, N.M., Azaev, M.S., and Smolina, M.P. (1995) Attempts to develop a vaccine against Ebola feverVoprosy Virusologii(in Russian)40 (6)257–260.

    Google Scholar 

  6. Merzlikin, N.V., Chepurnov, A.A., Istomina, N.N., Ofitserov, V.I., and Vorobyeva, M.S. (1995) Development and use of enzyme immunoassay test systems for the diagnosis of Ebola feverVoprosy Virusologii (in Russian) 40 (1)31–35.

    Google Scholar 

  7. Dedkova, L.M., Kudoiarova, N.M., Chepurnov, A.A., and Ofitserov, V.I. (1994) Composition and immunochemical properties of goat immunoglobulins against the Ebola virusVoprosy Virusologii (inRussian)39(5)229–231.

    Google Scholar 

  8. Moe, J.B., Lambert, R.D., and Lupton, H.W. (1981) Plaque assay for Ebola virusJ Clin. Microbial. 13 (4)791–793.

    Google Scholar 

  9. Cohn, E.J., Strong, L.E., and Hughes, W.L. (1946) Preparation and properties of serum and plasma proteins. IV. A System for the separation into fractions of the protein and lipoprotein components of biological tissues and fluidsJ. Amer. Chem. Soc.68 (3)459–475.

    Article  Google Scholar 

  10. Van der Groen, G., Jacob, W., and Pattyn, S.R. (1979) Ebola virus virulence for newborn miceJ Med. Virol. 4 (3)239–240.

    Article  Google Scholar 

  11. Krasnianskii, V.P., Mikhailov, V.V., Borisevich, I.V., Gradoboev, V.N., Evseev, A.A., and Pshenichnov, V.A. (1994) Preparation of hyperimmune horse serum against Ebola virusVoprosy Virusologii(in Russian)39 (2)91–92.

    Google Scholar 

  12. Ashmarin, I.P. and Vorob’ev, A.A. (1962)Statistical methods in microbiological investigationMedicine, Leningrad, p. 230. (in Russian)

    Google Scholar 

  13. Burgasov, P.N. (ed.) (1978) Handbook on vaccination and seroprophylaxis, Medicine, Moscow, p. 439 (in Russian)

    Google Scholar 

  14. Emond, R.T.D., Evans, B., Bowen, E.T.W., and Lloyd, G.N. (1977) A case of Ebola virus infectionBrit. Med. J. 2 (6086)541–544.

    Article  Google Scholar 

  15. Dedkova, L.M., Kudoyarova, N.M., Shaprov, V.N., Sabirov, A.N., and Offitserov, V.I. (1993) Antibodies of hyperimmune sera of animals. II. Subclasses of Immunoglobulin G from normal and hyperimmune sera of goat Siberian Biological Journal (in Russian)68–13.

    Google Scholar 

  16. Borisevich, I.V., Mikhailov, V.V., Krasnianskii, V.P., Gradoboev, V.N., Lebedinskaia, Ye.V., Potryvaeva, N.V., and Timan’kova G.D. (1995) Development and study of the properties of immunoglobulin against Ebola feverVoprosy Virusologii (in Russian) 40 (6)270–273.

    Google Scholar 

  17. Markin, V.A., Mikhailov, V.V., Krasnianskii, V.P., Borisevich, I.V., and Firsova, I.V. (1997) Developing principles for emergency prevention and treatment of Ebola feverVoprosy Virusologii (in Russian) 42 (1)31–34.

    Google Scholar 

  18. Jahrling, P.B., Geisbert, J., Swearengen, J.R., Jaax, G.P., Lewis, T., Huggins, J.W., Schmidt, J.J., LeDuc, J.W., and Peters, C.J. (1996) Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horsesArchives of Virology Supplementum 11135–140.

    Google Scholar 

  19. Ryabchikova, E.I., Kolesnikova, L.V., Smolina, M., Tkachev, V.V., Pereboeva, L.V., Baranova, S.B., Grazhdantseva, A.A., and Rassadkin, Yu.N. (1996) Ebola virus infection in guinea pigs: presumable role of granulomatosis inflammation ill pathogenesisArchives of Virology 141 (5)909–922.

    Article  Google Scholar 

  20. Fields, B.N., Knipe, D.M., Howley, P.M. (eds) (1996)Fields VirologyRaven Publishers, Philadelphia/New York.

    Google Scholar 

  21. Kudoyarova-Zubavichene, N.M., Sergeyev, N.N., Chepurnov, A.A., and Netesov, S.V. (1999) Preparation and Use of hyperimmune serum for prophylaxis and therapy of Ebola virus infection,.Journal of Infectious Diseases179SupplIS218–223.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Netesov, S.V. (2001). The Post Exposure Prophylactic Measures Against Viral BTW Agents. In: Kelle, A., Dando, M.R., Nixdorff, K. (eds) The Role of Biotechnology in Countering BTW Agents. NATO Science Series, vol 34. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0775-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-94-010-0775-7_20

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-6906-6

  • Online ISBN: 978-94-010-0775-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics